Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenue:    
Total Revenues $ 144,165 $ 166,619
Cost of sales:    
Cost of sales 120,807 134,194
Gross margin 23,358 32,425
Operating expenses:    
Sales and marketing 5,340 8,249
Product development 5,963 6,979
General and administrative 30,576 27,980
Provision for legal settlements 0 508
Amortization of intangible assets 6,142 7,799
Goodwill impairment 22,130 0
Total operating expenses 70,151 51,515
Loss from operations (46,793) (19,090)
Other (expense) income:    
Interest expense, net (22,587) (21,277)
Income (loss) from equity method investments including impairment losses (10,858) 2,129
Change in fair value of derivatives 207 938
Other income (expense), net 232 (179)
Loss before income taxes (79,799) (37,479)
Income tax expense 1,126 130
Net loss $ (80,925) $ (37,609)
Net loss per share – basic and diluted (in dollars per share) $ (21.77) $ (10.23)
Weighted-average shares – basic and diluted 3,718 3,673
Licensing and services    
Revenue:    
Total Revenues $ 135,645 $ 150,478
Cost of sales:    
Cost of sales 113,284 123,269
Equipment    
Revenue:    
Total Revenues 8,520 16,141
Cost of sales:    
Cost of sales $ 7,523 $ 10,925